Direct Intramyocardial Mesenchymal Stromal Cell Injections in Patients with Severe Refractory Angina: One-Year Follow-Up

Direct Intramyocardial Mesenchymal Stromal Cell Injections in Patients with Severe Refractory Angina: One-Year Follow-Up

In patients with stable coronary artery disease (CAD) and refractory angina, we performed direct intramyocardial injections of autologous mesenchymal stromal cells (MSC) and followed the safety and efficacy of the treatment for 12 months. A total of 31 patients with stable CAD, moderate to severe an...

Full description

Bibliographic Details
Main Authors: Mandana Haack-Sørensen, Tina Friis, Anders B. Mathiasen, Erik Jørgensen, Louise Hansen, Ebbe Dickmeiss, Annette Ekblond, Jens Kastrup M.D., D.MSc., FESC
Format: Article
Language:English
Published: SAGE Publishing 2013-03-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368912X636830

Internet

https://doi.org/10.3727/096368912X636830

Similar Items